News and Events

A 10-Year History of Teledermatology for Skin Cancer Management

15 December 2015

This Viewpoint describes a teledermatology network implemented to connect 56 primary care centers with the skin cancer and melanoma clinic of a university-based hospital in Seville, Spain, to address the problems associated with patient wait times.

Reaction of indoor tanners to Australian ban

10 December 2015

While their research indicates a high level of public support for the solarium ban in Australia, the authors of this study identify the need to monitor the tanning behaviours of previous users post-ban and their access to private sunbed use and other potentially dangerous methods of tanning (e.g. tanning injections).

Impact of youth/young adult advertising campaigns on all age groups

10 December 2015

Sustained youth-focused Australian advertising campaigns (for adolescents and young adults), when broadcast with sufficient TARPs (target audience rating points) during the summer months, continue to provide consistent beneficial impact on sun protection behaviors population-wide, according to the authors of a recently published study.

Public health advocacy in sunbed control

9 December 2015

In this article, Craig Sinclair and his co-authors highlight the role of incremental change as an effective pathway to securing more substantial changes in the longer term. They also highlighted that the changes in Australia [culminating in a total ban] “benefitted from a combination of strong, widely reported epidemiological evidence, the powerful personal stories of 2 people whose melanoma was associated with the use of tanning beds, media advocacy, and direct political representation by nongovernment agencies”.

Proportion of skin cancers prevented by regular sunscreen use

9 December 2015

Most skin cancers are preventable, and prevailing levels of sunscreen use probably reduced skin cancer incidence by 10-15% in Australia, according to a recently published study. The authors conclude that sunscreen should be a component of a comprehensive sun protection strategy.

Economic impact of skin cancer in New South Wales

9 December 2015

This open-access publication provides evidence on the economic costs associated with skin cancer in New South Wales that is based upon based on the latest epidemiological and economic evidence. According to the authors, there are still large knowledge gaps in understanding the wider impact of skin cancer on society. This lack of data means that the study most likely under-estimates the true cost of skin cancer in that state.

Sun-exposed normal skin shown to carry cancer-causing mutations

9 December 2015

A recent study has found a ‘surprisingly higher burden of mutations, higher than that of many tumours, according to an editorial summary of the study. As concluded by the study authors, “aged sun-exposed skin is a patchwork of thousands of evolving clones with over a quarter of cells carrying cancer-causing mutations while maintaining the physiological functions of epidermis”.

PHARMAC releases review of pembrolizumab (Keytruda)

2 December 2015

PHARMAC has today released the outcome of its clinical committees’ review of pembrolizumab (Keytruda). Based on their review of the available evidence the committees recommended pembrolizumab be funded and gave this recommendation a low priority. PHARMAC will continue working with the supplier to work towards a funding decision for this medicine.

Views sought on extra protections from sunbeds

30 November 2015

Health Minister Jonathan Coleman announced today that public consultation has begun on proposals for additional protection from the use of commercial sunbeds in New Zealand. These proposals include licensing and training of operators.